Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 4;26(3):340–351. doi: 10.3350/cmh.2020.0004

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 by The Korean Association for the Study of the Liver

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 2. — HCC in a 53-year-old man with chronic hepatitis B. On the arterial (A), portal venous (B), and hepatobiliary phase (C) images, after administration of hepatobiliary agent, a 39-mm liver mass (arrows) showed arterial phase hyperenhancement without washout in the portal venous phase, while showing hypointensity in the hepatobiliary phase. The mass was categorized as LR-4 by LI-RADS 2018, but classified as definite HCC by KLCA-NCC 2018. HCC, hepatocellular carcinoma; LI-RADS, Liver Imaging Reporting and Data System; KLCA-NCC, Korean Liver Cancer Association-National Cancer Center.